All Stories

  1. Multifunctional compounds for the treatment of skin diseases: synthesis, inhibition of skin aging-related enzymes, docking studies, and antioxidant activity
  2. The Role of Hydrogen Bond Donors and Intramolecular Hydrogen Bonding in Modulating Blood–Brain Barrier Permeability: Implications for CNS Drug Design
  3. Design, Synthesis, and Evaluation of Coumarin‐Rasagiline Hybrids as Multifunctional Neuroprotective Agents
  4. Exploring 6‐Hydroxy‐3‐Aryl/Heteroarylcoumarins as Promising Candidates Against Trypanosoma cruzi
  5. The futility of the familiar: rethinking strategies for the development of small molecules for neurodegenerative disorders
  6. 2-Arylbenzofurans as Selective Cholinesterase Inhibitors: Design, Synthesis, and Evaluation as Alzheimer’s Disease Agents
  7. Biosafety Evaluation of 6,7‐Dihydroxy‐3‐(2‐Nitrophenyl)Coumarin in Human Cells
  8. The Role of Trifluoromethyl and Trifluoromethoxy Groups in Medicinal Chemistry: Implications for Drug Design
  9. Exploring Trisubstituted adenine derivatives as adenosine A1 receptor ligands with antagonist activity: Synthesis, biological evaluation and molecular modelling
  10. A New Class of Benzo[b]thiophene-chalcones as Cholinesterase Inhibitors: Synthesis, Biological Evaluation, Molecular Docking and ADME Studies
  11. Seaweeds as Source of Bioactive Pigments with Neuroprotective and/or Anti-Neurodegenerative Activities: Astaxanthin and Fucoxanthin
  12. Empowering Voices: Inspiring Women in Medicinal Chemistry
  13. Empowering Voices: Inspiring Women in Medicinal Chemistry
  14. N-(coumarin-3-yl)cinnamamide Promotes Immunomodulatory, Neuroprotective, and Lung Function-Preserving Effects during Severe Malaria
  15. Front Cover: Design of 3‐Phenylcoumarins and 3‐Thienylcoumarins as Potent Xanthine Oxidase Inhibitors: Synthesis, Biological Evaluation, and Docking Studies (ChemMedChem 21/2023)
  16. Study of the DNA damage and cell death in human peripheral blood mononuclear and HepG2/C3A cells exposed to the synthetic 3-(3-hydroxyphenyl)-7-hydroxycoumarin
  17. Design of 3‐Phenylcoumarins and 3‐Thienylcoumarins as Potent Xanthine Oxidase Inhibitors: Synthesis, Biological Evaluation, and Docking Studies
  18. Evaluation of in vitro cytotoxic and genotoxic effects of the 3‐(3,4‐dihydroxyphenyl)‐8‐hydroxycoumarin
  19. Oxidation-labile linkers for controlled drug delivery
  20. 8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin's antidepressant profile: Synthesis, biological evaluation and docking studies
  21. In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies
  22. Propargylamine: an Important Moiety in Drug Discovery
  23. Recent Advances in Biologically Active Coumarins from Marine Sources: Synthesis and Evaluation
  24. Front Cover: Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives (ChemMedChem 21/2022)
  25. Hydroxy-3-Phenylcoumarins as Multitarget Compounds for Skin Aging Diseases: Synthesis, Molecular Docking and Tyrosinase, Elastase, Collagenase and Hyaluronidase Inhibition, and Sun Protection Factor
  26. Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives
  27. Cytogenotoxicity assessment of 3‐(3,4‐dihydroxyphenyl)‐7,8‐dihydroxycoumarin on HepG2/C3A cells and leukocytes
  28. Thiocoumarins: From the Synthesis to the Biological Applications
  29. Medicinal Chemistry in Portugal and Spain: A Strong Iberian Alliance
  30. Treating Neurodegenerative Diseases with Multitarget Drugs: An Interview With Maria João Matos
  31. A comprehensive ethnobotanical profile ofOcimum campechianum(Lamiaceae): from traditional medicine to phytochemical and pharmacological evidences
  32. Single Mutation on Trastuzumab Modulates the Stability of Antibody–Drug Conjugates Built Using Acetal-Based Linkers and Thiol-Maleimide Chemistry
  33. Structural Insight of New Butyrylcholinesterase Inhibitors Based on Benzylbenzofuran Scaffold
  34. Synthesis and study of the trypanocidal activity of catechol-containing 3-arylcoumarins, inclusion in β-cyclodextrin complexes and combination with benznidazole
  35. Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin
  36. 8-Amide and 8-Carbamate Substitution Patterns as Modulators of 7-Hydroxy-4-Methylcoumarin's Antidepressant Profile: Synthesis, MAO Inhibition, Cytotoxicity and Docking Studies
  37. 3-Phenylcoumarins as a Privileged Scaffold in Medicinal Chemistry: The Landmarks of the Past Decade
  38. Coumarin and Its Derivatives—Editorial
  39. Study of a Selected Series of 3‐ and 4‐Arylcoumarins as Antifungal Agents against Dermatophytic Fungi: T. rubrum and T. mentagrophytes
  40. Computer-aided Design of Coumarins for Neurodegenerative Diseases: Trends of the Last Decade
  41. Theobroma cacao L. compounds: Theoretical study and molecular modeling as inhibitors of main SARS-CoV-2 protease
  42. Multitarget Therapeutic Approaches for Alzheimer's and Parkinson's Diseases: An Opportunity or an illusion?
  43. Medicinal Chemistry in Portugal and Spain: A Strong Iberian Alliance — Call for Papers
  44. Chemical and biological analysis of 4-acyloxy-3-nitrocoumarins as trypanocidal agents
  45. Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors
  46. Study of 3-(4’-Nitrobenzamido)coumarin using an Alzheimer’s Disease Model
  47. Trending Topics on Coumarin and Its Derivatives in 2020
  48. Sequential dual site-selective protein labelling enabled by lysine modification
  49. Looking for new xanthine oxidase inhibitors: 3-Phenylcoumarins versus 2-phenylbenzofurans
  50. Adenosine Receptor Ligands: Coumarin–Chalcone Hybrids as Modulating Agents on the Activity of hARs
  51. 7‐Amidocoumarins as Multitarget Agents against Neurodegenerative Diseases: Substitution Pattern Modulation
  52. Discovery and optimization of 3-thiophenylcoumarins as novel agents against Parkinson’s disease: Synthesis, in vitro and in vivo studies
  53. 3-Arylcoumarins as highly potent and selective monoamine oxidase B inhibitors: Which chemical features matter?
  54. Coumarin‐Rasagiline Hybrids as Potent and Selective hMAO‐B Inhibitors, Antioxidants, and Neuroprotective Agents
  55. Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists
  56. Artificial Intelligence Applied to Flavonoid Data in Food Matrices
  57. Facing Novel Challenges in Neurodegenerative Diseases Drug Discovery: From Small Molecules to Targeted Therapies
  58. Antibacterial Activity and Molecular Docking Studies of a Selected Series of Hydroxy-3-arylcoumarins
  59. Enhancement of the Anti-Aggregation Activity of a Molecular Chaperone Using a Rationally Designed Post-Translational Modification
  60. Design, Synthesis and Docking Calculations of Prenylated Chalcones as Selective Monoamine Oxidase B Inhibitors with Antioxidant Activity
  61. Quaternization of Vinyl/Alkynyl Pyridine Enables Ultrafast Cysteine‐Selective Protein Modification and Charge Modulation
  62. Quaternization of Vinyl/Alkynyl Pyridine Enables Ultrafast Cysteine‐Selective Protein Modification and Charge Modulation
  63. Synthesis, molecular docking and cholinesterase inhibitory activity of hydroxylated 2-phenylbenzofuran derivatives
  64. Targeting α -(1,4)-Glucosidase in Diabetes Mellitus Type 2: The Role of New Synthetic Coumarins as Potent Inhibitors
  65. Novel Coumarin-Quinoline Hybrids: Design of Multitarget Compounds for Alzheimer's Disease
  66. Lysine Bioconjugation on Native Albumin with a Sulfonyl Acrylate Reagent
  67. Coumarin derivatives as promising xanthine oxidase inhibitors
  68. Efficient and irreversible antibody–cysteine bioconjugation using carbonylacrylic reagents
  69. PEGylated PLGA Nanoparticles As a Smart Carrier to Increase the Cellular Uptake of a Coumarin-Based Monoamine Oxidase B Inhibitor
  70. Synthesis and Biological Evaluation of Homogeneous Thiol-Linked NHC*-Au-Albumin and -Trastuzumab Bioconjugates
  71. Unexpected one-step synthesis of 3-benzoyl-2-phenylbenzofurans under Wittig conditions
  72. A silicon-labelled amino acid suitable for late-stage fluorination and unexpected oxidative cleavage reactions in the preparation of a key intermediate in the Strecker synthesis
  73. Evaluation of trypanocidal and antioxidant activities of a selected series of 3-amidocoumarins
  74. Learning from nature: the role of albumin in drug delivery
  75. Trends in patented chromones for skin diseases
  76. Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease
  77. Chemo- and Regioselective Lysine Modification on Native Proteins
  78. Coumarins as Promising Scaffold for the Treatment of Age-related Diseases – An Overview of the Last Five Years
  79. A thioether-directed palladium-cleavable linker for targeted bioorthogonal drug decaging
  80. Chemoselective Installation of Amine Bonds on Proteins through Aza-Michael Ligation
  81. Coumarins and adenosine receptors: New perceptions in structure-affinity relationships
  82. Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?
  83. New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies
  84. Heterocyclic Antioxidants in Nature: Coumarins
  85. Synthesis, antioxidant and antichagasic properties of a selected series of hydroxy-3-arylcoumarins
  86. In silico genotoxicity of coumarins: application of the Phenol-Explorer food database to functional food science
  87. MAO inhibitory activity of bromo-2-phenylbenzofurans: synthesis, in vitro study, and docking calculations
  88. Trends in therapeutic drug conjugates for bacterial diseases: a patent review
  89. Structural elucidation of a series of 6-methyl-3-carboxamidocoumarins
  90. In silico study of new structural alerts of agents clastogenic
  91. Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents
  92. Evaluation of Antioxidant and Antitrypanosomal Properties of a Selected Series of Synthetic 3-Carboxamidocoumarins
  93. Facing Chagas' Disease: Trypanocidal Properties of New Coumarinchalcone Scaffolds
  94. 6-Methyl-2-oxo-N-(quinolin-6-yl)-2H-chromene-3-carboxamide: crystal structure and Hirshfeld surface analysis
  95. Crystal structures of three 6-substituted coumarin-3-carboxamide derivatives
  96. 2-Phenylbenzofuran derivatives as butyrylcholinesterase inhibitors: Synthesis, biological activity and molecular modeling
  97. Exploring coumarin potentialities: development of new enzymatic inhibitors based on the 6-methyl-3-carboxamidocoumarin scaffold
  98. Progress in the development of small molecules as new human A3 adenosine receptor ligands based on the 3-thiophenylcoumarin core
  99. Prediction of the total antioxidant capacity of food based on artificial intelligence algorithms
  100. Design, synthesis and antibacterial study of new potent and selective coumarin–chalcone derivatives for the treatment of tenacibaculosis
  101. 3-Amidocoumarins as Potential Multifunctional Agents against Neurodegenerative Diseases
  102. Coumarins — An Important Class of Phytochemicals
  103. Development of novel adenosine receptor ligands based on the 3-amidocoumarin scaffold
  104. Bioactive Coumarins from Marine Sources: Origin, Structural Features and Pharmacological Properties
  105. In silico clastogenic activity of dietary phenolic acids
  106. Interest of Antioxidant Agents in Parasitic Diseases. The Case Study of Coumarins
  107. Oxidative Stress and Neurodegenerative Diseases: Looking for a Therapeutic Solution Inspired on Benzopyran Chemistry
  108. Study of Coumarin-Resveratrol Hybrids as Potent Antioxidant Compounds
  109. Potent and selective MAO-B inhibitory activity: Amino- versus nitro-3-arylcoumarin derivatives
  110. Potential pharmacological uses of chalcones: a patent review (from June 2011 – 2014)
  111. Design and discovery of tyrosinase inhibitors based on a coumarin scaffold
  112. Back Cover: Insight into the Interactions between Novel Coumarin Derivatives and Human A3 Adenosine Receptors (ChemMedChem 10/2014)
  113. Insight into the Interactions between Novel Coumarin Derivatives and Human A3 Adenosine Receptors
  114. Synthesis and electrochemical study of new 3-(hydroxyphenyl)benzo[f]coumarins
  115. Insight into the Functional and Structural Properties of 3‐Arylcoumarin as an Interesting Scaffold in Monoamine Oxidase B Inhibition
  116. Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases
  117. Chromone: A Valid Scaffold in Medicinal Chemistry
  118. Synthesis and evaluation of antioxidant and trypanocidal properties of a selected series of coumarin derivatives
  119. Comparative study of the 3-phenylcoumarin scaffold: Synthesis, X-ray structural analysis and semiempirical calculations of a selected series of compounds
  120. Synthesis and adenosine receptors binding affinities of a series of 3-arylcoumarins
  121. QSAR and Complex Network Recognition of miRNAs in Stem Cells
  122. Synthesis and Electrochemical and Biological Studies of Novel Coumarin–Chalcone Hybrid Compounds
  123. Remarkable antioxidant properties of a series of hydroxy-3-arylcoumarins
  124. Synthesis, NMR characterization, X-ray structural analysis and theoretical calculations of amide and ester derivatives of the coumarin scaffold
  125. Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: Synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study
  126. (1S,2S,5S)-2-Methyl-3-oxo-5-(prop-1-en-2-yl)cyclohexane-1-carbonitrile
  127. [(2S,3aR,6aR)-5-Oxohexahydrofuro[3,2-b]furan-2-yl]methyl acetate
  128. MAO Inhibitory Activity of 2‐Arylbenzofurans versus 3‐Arylcoumarins: Synthesis, in vitro Study, and Docking Calculations
  129. ChemInform Abstract: Improved Synthesis of 3‐(Aminoaryl)coumarins.
  130. Editorial (Hot Topic: Monoamine Oxidase as a Target in Medicinal Chemistry and Drug Discovery)
  131. Focusing on New Monoamine Oxidase Inhibitors: Differently Substituted Coumarins As An Interesting Scaffold
  132. Chalcone-based derivatives as new scaffolds for h A3 adenosine receptor antagonists
  133. Synthesis and Structure-Activity Relationships of Novel Amino/Nitro Substituted 3-Arylcoumarins as Antibacterial Agents
  134. Synthesis of coumarin–chalcone hybrids and evaluation of their antioxidant and trypanocidal properties
  135. New hydroxylated 3-arylcoumarins, synthesis and electrochemical study
  136. Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives
  137. N-(2-Oxo-2H-chromen-3-yl)cyclohexanecarboxamide
  138. Looking for New Targets: Simple Coumarins as Antibacterial Agents
  139. Editorial (Hot Topic: Monoamine Oxidase as a Target in Medicinal Chemistry and Drug Discovery)
  140. Focusing on New Monoamine Oxidase Inhibitors: Differently Substituted Coumarins As An Interesting Scaffold
  141. Monoamine Oxidase Inhibitors: Ten Years of Docking Studies
  142. Looking for New Targets: Simple Coumarins as Antibacterial Agents
  143. Monoamino Oxidase A: An Interesting Pharmacological Target for the Development of Multi-Target QSAR
  144. Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance
  145. 3-Phenylcoumarin
  146. In search for new chemical entities as adenosine receptor ligands: Development of agents based on benzo-γ-pyrone skeleton
  147. Antioxidant and Pro-Oxidant Effects of Polyphenolic Compounds and Structure-Activity Relationship Evidence
  148. Tyrosine-like condensed derivatives as tyrosinase inhibitors
  149. Structural Alerts for Predicting Clastogenic Activity of Pro-oxidant Flavonoid Compounds
  150. Thyroid carcinoma in children and adolescents: A retrospective review
  151. 8-Substituted 3-Arylcoumarins as Potent and Selective MAO-B Inhibitors: Synthesis, Pharmacological Evaluation, and Docking Studies
  152. 3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease
  153. Improved Synthesis of 3-(Aminoaryl)coumarins
  154. Hydroxycoumarins as selective MAO-B inhibitors
  155. Synthesis and Study of a Series of 3-Arylcoumarins as Potent and Selective Monoamine Oxidase B Inhibitors
  156. ChemInform Abstract: New Halogenated Phenylcoumarins as Tyrosinase Inhibitors.
  157. MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins
  158. New halogenated phenylcoumarins as tyrosinase inhibitors
  159. ChemInform Abstract: Synthesis of 3‐Arylcoumarins via Suzuki Cross‐Coupling Reactions of 3‐Chlorocoumarin.
  160. Synthesis of 3-arylcoumarins via Suzuki-cross-coupling reactions of 3-chlorocoumarin
  161. New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors
  162. Regioselective Synthesis of Bromo-Substituted 3-Arylcoumarins
  163. ChemInform Abstract: A New Series of 3‐Phenylcoumarins as Potent and Selective MAO‐B Inhibitors.
  164. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors
  165. Tyrosinase Inhibitor Activity of Coumarin-Resveratrol Hybrids
  166. Synthesis of Regioisomeric Functionalized Benzodifurans and Angelicins
  167. A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors
  168. Silicones—A Key Ingredient in Cosmetic and Toiletry Formulations